HomeCONGRESS

CONGRESS

EuroPCR 2026 | Could clopidogrel replace aspirin as monotherapy after PCI?

This presentation, delivered during EuroPCR 2026, analyzed the clinical outcomes of clopidogrel monotherapy versus aspirin in patients...

EuroPCR 2026 | Are bioresorbable stents making a comeback? Five-year results of FUTURE-II with Firesorb

The first bioresorbable coronary scaffolds generated great expectations because of their potential to restore vascular physiology after...

EuroPCR 2026 | Coronary bioadaptor: fewer events regardless of IVUS or FFR guidance

Despite the increasing use of intracoronary imaging and physiology, stent-related events continue to occur at an annual...

EuroPCR 2026 | Is localized anticoagulation the next step for coronary stents?

The DESyne BDS Plus stent was developed as a thin-strut, bioabsorbable polymer drug-eluting stent that combines sirolimus...

EuroPCR 2026 | Restoring vascular physiology: 4-year results of the BIOADAPTOR-RCT

Despite advances in drug-eluting stents, device-related events continue to increase beyond the first year after angioplasty. In...

EuroPCR 2026 | Orbital versus rotational atherectomy: different impact on the microcirculation?

Not all calcium modification devices interact with the treated vessel in the same way. Although the clinical...

EuroPCR 2026 | Rotational atherectomy, orbital atherectomy, or lithotripsy: does device selection modify prognosis?

In the complex setting of severe coronary calcification, different plaque modification strategies have been incorporated into the...

EuroPCR 2026 | Does calcium morphology define the choice between IVL and cutting balloon?

The treatment of calcified coronary lesions remains one of the most technically challenging scenarios in contemporary angioplasty....